Increased nuchal translucency and congenital heart disease

Early Human Development

Volumn 88, Issue 5, 2012, Pages 261-267

  Mogra, Ritu ^a   Alabbad, Nasser ^b   Hyett, Jon ^a  

^a University of Sydney   (Australia)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Congenital heart disease; Nuchal translucency; Prenatal diagnosis; Ultrasound

Indexed keywords

ANAMNESIS; ANEUPLOIDY; CHROMOSOME ABERRATION; CONGENITAL HEART DISEASE; CYSTIC LYMPHANGIOMA; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DOWN SYNDROME; DUCTUS VENOSUS; ECHOCARDIOGRAPHY; EMBRYO DEVELOPMENT; FETUS; FETUS KARYOTYPING; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEART DEVELOPMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MATERNAL AGE; MEDICAL RESEARCH; NUCHAL TRANSLUCENCY MEASUREMENT; PHENOTYPIC VARIATION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRENATAL SCREENING; RADIODIAGNOSIS; REVIEW; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; TRISOMY 21; TURNER SYNDROME;

CHROMOSOME DISORDERS; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PRACTICE GUIDELINES AS TOPIC;

EID: 84859824168     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.02.009     Document Type: Review

References (51)

1. Snijders R.J., Gosden C.M. Fetal nuchal oedema: associated malformations and chromosomal defects. Fetal Diagn Ther 1992, 7:123-131.
2. Azar G.B., Snijders R.J., Gosden C., Nicolaides K.H. Fetal nuchal cystic hygromata: associated malformations and chromosomal defects. Fetal Diagn Ther 1991, 6:46-57.
3. Clark E.B. Neck web and congenital heart defects: a pathogenic association in 45 X-O Turner syndrome?. Teratology 1984, 29:355-361.
4. Berdahl L.D., Wenstrom K.D., Hanson J.W. Web neck anomaly and in association with congenital heart disease. Am J Med Genet 1995, 56:304-307.
5. Chitayat D., Kalousek D.K., Bamforth J.S. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma. Am J Med Genet 1989, 33:352-356.
6. Surerus E., Huggon I.C., Allan L.D. Turner's syndrome in fetal life. Ultrasound Obstet Gynecol 2003, 22:264-267.
7. Wright D., Kagan K.O., Molina F.S., Gazzoni A., Nicolaides K.H. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008, 31:376-383.
8. Chervenak F.A., Isaacson G., Blakemore K.J., Breg W.R., Hobbins J.C., Berkowitz R.L., et al. Fetal cystic hygroma. Cause and natural history. N Engl J Med 1983, 309:822-825.
9. von Kaisenberg C.S., Wilting J., Dörk T., et al. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls. Mol Hum Reprod 2010, 16:778-789.
10. Cox D.R. Mouse trisomy 16 as an animal model of human trisomy 21: a new approach for studying the pathogenesis of Down syndrome. Mead Johnson Symp Perinat Dev Med 1983, 22:23-27.
11. Haak M.C., Bartelings M.M., Jackson D.G., Webb S., van Vugt J.M.G., Gittenberger de Groot A.C. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002, 17:1086-1092.
12. Haak M.C., van Vugt J.M.G. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update 2003, 9:175-184.
13. Achiron R., Yagel S., Weissman A., Lipitz S., Mashiach S., Goldman B. Fetal lateral neck cysts: early second trimester transvaginal diagnosis, natural history and clinical significance. Ultrasound Obstet Gynecol 1995, 6:396-399.
14. Van Heesch P.N., Struijk P.C., Bandenburg H., Steegers E.A., Wildschut H.I. Jugular lymphatic sacs in the first trimester of pregnancy: the prevalence and the potential value in screening for chromosomal abnormalities. J Perinat Med 2008, 36:518-522.
15. Hyett J.A., Moscoso G., Nicolaides K.H. First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. Am J Obstet Gynecol 1995, 172:1411-1413.
16. Hyett A., Moscoso G., Nicolaides K.H. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997, 69:207-216.
17. Hyett J.A., Brizot M.L., von Kaisenbeg C.S., Mckie A.T., Farzaneh F., Nicolaides K.H. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol 1996, 87:506-510.
18. Hyett J., Moscoso G., Papapanagiotou G., Perdu M., Nicolaides K. Abnormalities of the heart and great vessels in chromosomally normal fetuses with increased nuchal translucency thickness at 10-13weeks of gestation. Ultrasound Obstet Gynecol 1996, 7:245-250.
19. Hyett J.A., Perdu M., Sharland G.K., Snijders R.S.M., Nicolaides K. H increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997, 10:242-246.
20. Lopes L.M., Brizot M.L., Lopes M.A., Ayello V.D., Schultz R., Zugaib M. Structural and functional cardiac abnormalities identified prior to 16weeks' gestation in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 2003, 22:470-478.
21. Galindo A., Comas C., Martínez J.M., Gutiérrez-Larraya F., Carrera J.M., Puerto B., et al. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14weeks of gestation. J Matern Fetal Neonatal Med 2003, 13:163-170.
22. McAuliffe F.M., Hornberger L.K., Winsor S., Chitayat D., Chong K., Johnson J.A. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study. Am J Obstet Gynecol 2004, 191:1486-1490.
23. Atzei A., Gajewska K., Huggon I.C., Allan L., Nicolaides K.H. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005, 26:154-157.
24. Clur S.A., Mathijssen I.B., Pajkrt E., et al. Structural heart defects associated with an increased nuchal translucency: 9years experience in a referral centre. Prenat Diagn 2008, 28:347-354.
25. Ghi T., Huggon I.C., Zosmer N., Nicolaides K.H. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001, 18:610-614.
26. Simpson J.M., Sharland G.K. Nuchal translucency and congenital heart defects:heart failure or not?. Ultrasound Obstet Gynecol 2000, 16:30-36.
27. Vogel M., Sharland G.K., McElhinney D.B., Zidere V., Simpson J.M., Miller O.I., et al. Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotype. Cardiol Young 2009, 19:441-445.
28. Carvalho J.S., Mavrides E., Shinebourne E.A., Campbell S., Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002, 88:387-391.
29. Hyett J., Perdu M., Sharland G., Snijders R., Nicolaides K.H. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999, 318:81-85.
30. Mavrides E., Cobian-Sanchez F., Tekay A., Moscoso G., Campbell S., Thilaganathan B., et al. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001, 17:106-110.
31. Michailidis G.D., Economides D.L. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001, 17:102-105.
32. Hafner E., Schuller T., Metzenbauer M., Schuchter K., Philipp K. Increased nuchal translucency and congenital heart defects in a low-risk population. Prenat Diagn 2003, 23:985-989.
33. Bahado-Singh R.O., Wapner R., Thom E., Zachary J., Platt L., Mahoney M.J., et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005, 192:1357-1361.
34. Bruns R.F., Moron A.F., Murta C.G.V., de Andfrade Goncalves L.F., Zamith M.M. The role of nuchal translucency in the screening of congenital heart defects. Arq Bras Cardiol 2006, 87:272-279.
35. Westin M., Saltvedt S., Bergman G., Almström H., Grunewald C., Valentin L. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses. Ultrasound Obstet Gynecol 2006, 27:632-639.
36. Muller M.A., Clur S.A., Timmerman E., Bilardo C.M. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies. Prenat Diagn 2007, 27:164-169.
37. Syngelaki A., Chelemen T., Dagklis T., Allan L., Nicolaides K.H. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13weeks. Prenat Diagn 2011, 31:90-102.
38. Huggon I.C., DeFigueiredo D.B., Allan L.D. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14weeks of gestation. Heart 2003, 89:1071-1073.
39. +6week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006, 27:609-612.
40. Maiz N., Valencia C., Kagan K.O., Wright D., Nicolaides K.H. Ductus venosus Doppler in screening for trisomies 21, 18, and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009, 33:512-517.
41. Matias A., Huggon I., Areias J.C., Montenegro N., Nicolaides K.H. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14weeks. Ultrasound Obstet Gynecol 1999, 14:307-310.
42. Bilardo C.M., Muller M.A., Zikulnig L., Schipper M., Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001, 17:288-294.
43. Murta C.G., Moron A.F., Avila M.A., Weiner C.P. Application of ductus venosus Doppler elocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 2002, 1:308-314.
44. Zoppi M.A., Putzolu M., Ibba R.M., Floris M., Monni G. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002, 17:52-57.
45. Favre R., Cherif Y., Kohler M., Kohler A., Hunsinger M.C., Bouffet N., et al. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 2003, 21:239-243.
46. Haak M.C., Twisk J.W.R., Bartelings M.M., Gittenberger-de Groot A.C., van Vugt J.M.G. Ductus venosus flow velocities in relation to the cardiac defects in first trimester fetuses with enlarged nuchal translucency. Am J Obstet Gynecol 2003, 188:727-733.
47. Toyama J.M., Brizot M.L., Liao A.W., Lopes L.M., Nomura R.M.Y., Saldanha F.A.T., et al. Ductus venosus blood flow assessment at 11 to 14weeks of gestation and fetal outcome. Ultrasound Obstet Gynecol 2004, 23:341-345.
48. Maiz N., Plasencia W., Daklis T., Faros E., Nicolaides K. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008, 31:256-260.
49. Timmerman E., Clur S.A., Pajkrt E., Bilardo C.M. First trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects. Ultrasound Obstet Gynecol 2010, 36:668-675.
50. Chelemen T., Syngelaki A., Maiz N., Allan L., Nicolaides K.H. Contribution of ductus venosus Doppler in first trimester screening for major cardiac defects. Fetal Diagn Ther 2011, 29:127-134.
51. Pereira S., Ganapathy R., Syngelaki A., Maiz N., Nicolaides K.H. Contribution of fetal tricuspid regurgitation in first trimester screening for major cardiac defects. Obstet Gynecol 2011, 117:1384-1391.